Redefining the genomics landscape to navigate the future of personalized medicine

Initiated by genomic testing, genomic medicine is now firmly established as a vital component of a modern healthcare system. With 80% of rare diseases having a genetic basis, genomic testing can reduce the time and number of hospital visits required to arrive at a diagnosis, improving patient experience, patient health outcomes, and total cost to the healthcare system. Genomics also plays a part in common diseases like asthma where genomic knowledge and information can assist healthcare professionals to better monitor and treat symptoms.

In this whitepaper, Revvity demonstrates how its comprehensive biochemical and genetic analysis, quick turnaround times, and ability to process large amounts of samples can aid in early intervention and management of genetic disorders in newborns.